Pharmacists are well-positioned to deliver what’s needed to meet the clinical and economic burdens of community healthcare, particularly when it comes to diabetes care.
Lilly also will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin.
Affordability, supply chain constraints and access to healthcare are on everyone’s mind these days, but for people with diabetes, these are ongoing issues.